VIP産生腫瘍
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: A population-based analysis.
- Shen C1, Shih YC, Xu Y, Yao JC.Author information 1Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.AbstractBACKGROUND: Octreotide long-acting repeatable (LAR) is indicated for the treatment of carcinoid syndrome and diarrhea related to VIPoma, and may delay tumor growth in patients with neuroendocrine tumors (NETs). To the authors' knowledge, the pattern of octreotide LAR use in clinical practice and its impact on survival outcomes has not been well documented.
- Cancer.Cancer.2014 Mar 26. doi: 10.1002/cncr.28653. [Epub ahead of print]
- BACKGROUND: Octreotide long-acting repeatable (LAR) is indicated for the treatment of carcinoid syndrome and diarrhea related to VIPoma, and may delay tumor growth in patients with neuroendocrine tumors (NETs). To the authors' knowledge, the pattern of octreotide LAR use in clinical practice and its
- PMID 24676892
- Enucleation of pancreatic lesions: indications, outcomes, and risk factors for clinical pancreatic fistula.
- Zhang T1, Xu J, Wang T, Liao Q, Dai M, Zhao Y.Author information 1Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China.AbstractBACKGROUND: There are few large samples and single-center series that focus on the outcomes of pancreatic enucleation and risk factors for clinical pancreatic fistula (PF). This study aimed to evaluate the indications, short- and long-term results, and risk factors for clinical PF after pancreatic enucleation.
- Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.J Gastrointest Surg.2013 Dec;17(12):2099-104. doi: 10.1007/s11605-013-2355-6. Epub 2013 Oct 8.
- BACKGROUND: There are few large samples and single-center series that focus on the outcomes of pancreatic enucleation and risk factors for clinical pancreatic fistula (PF). This study aimed to evaluate the indications, short- and long-term results, and risk factors for clinical PF after pancreatic e
- PMID 24101446
- [Chronic diarrhea in 43-year-old man].
- Larcher R1, Andrieu JM, Ramdani M, Passebois L, Favier L, Oziol E, Duffau P.Author information 1Service de médecine interne, centre hospitalier de Béziers, ZAC de Montimaran, 2, rue Valentin-Haüy, BP 740, 34525 Béziers, France.KEYWORDS: Chronic diarrhea, Diarrhée chronique, Syndrome de Verner-Morrisson, VIPoma, VIPome, Verner-Morrisson syndrome
- La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne.Rev Med Interne.2013 Dec;34(12):780-2. doi: 10.1016/j.revmed.2013.06.010. Epub 2013 Sep 5.
- PMID 24011846
Japanese Journal
- 膵内分泌腫瘍におけるソマトスタチン受容体とオクトレオチド
- The morphology and neuroendocrine profile of pancreatic epithelial VIPomas and extrapancreatic, VIP producing, neurogenic tumors
- Pancreatic polypeptide in insulinomas, gastrinomas, VIPomas, and glucagonomas
Related Pictures
★リンクテーブル★
[★]
- 英
- VIPoma, VIPomas
- 同
- VIP産生腺腫、血管活性腸ポリペプチド腫瘍
- 関
- 膵性コレラ、ヴェルナー・モリソン症候群、水様下痢低カリウム血症無胃酸症候群、VIP産生腫瘍症候群
- VIP